Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy

E-ISSN： 1875-533x|13|15|1839-1843

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.15, 2006-06, pp. : 1839-1843

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucokinase activators as new type 2 diabetes therapeutic agents

By Sarabu Ramakanth Berthel Steven J Kester Robert F Tilley Jefferson W

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 759-768

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Activators of the Insulin Receptor: Potential New Therapeutic Agents for the Treatment of Diabetes Mellitus

Current Medicinal Chemistry, Vol. 9, Iss. 24, 2002-12 ,pp. : 2231-2242

Bentham Science Publishers

Access to resources Recommend Favorite

Glucokinase activators in diabetes management

By Coghlan Matthew Leighton Brendan

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 145-167

Informa Healthcare

Access to resources Recommend Favorite

Glucokinase Activators for the Potential Treatment of Type 2 Diabetes

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 17, 2008-11 ,pp. : 1524-1532

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-lowering agents and new onset diabetes mellitus

By Athyros Vasilios G Tziomalos Konstantinos Karagiannis Asterios Mikhailidis Dimitri P

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 1965-1970

Informa Healthcare

Access to resources Recommend Favorite